All
Study says mycosis fungoides responds well to biological - modifier therapies
December 5th 2006National report - According to a study published in the November issue of the Journal of the American Academy of Dermatology, interleukin-12 (IL-12) produces a partial response rate of 43 percent in patients with previously treated mycosis fungoides.
Animal tests show promise for new antibody technology that fights skin cancer
December 5th 2006San Francisco ? Officials of Pain Therapeutics Inc., a biopharmaceutical company based here, is reporting that a proof-of-concept animal study of its new antibody technology for the treatment of skin cancer has produced promising results.
Are your winter-rosy cheeks a little too rosy?
December 1st 2006An inflammatory skin disease shared by the likes of Princess Di, Bill Clinton and W.C.Fields, rosacea can start innocently with a flush on your cheeks that seems to last just a little too long. You may notice it after working out, eating spicy foods or even sipping a glass of red wine.
Making the most of pre-op evaluation
December 1st 2006Wilkes-Barre, Pa. - A careful preoperative evaluation to acquire a thorough understanding of individual risk factors is the foundation for success when performing dermatologic surgery in older patients, Christine E. Cabell, M.D., tells Dermatology Times.